Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
This study will assess the effect of vildagliptin on left ventricular function in patients
with type 2 diabetes and congestive heart failure (NYHA Class I-III). Effect on HbA1c and
overall safety and tolerability will also be assessed.